|Day Low/High||77.11 / 79.68|
|52 Wk Low/High||20.39 / 82.18|
Investors in Esperion Therapeutics Inc saw new options begin trading this week, for the September 21st expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 231 days until expiration the newly trading contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.
In recent trading, shares of Esperion Therapeutics Inc have crossed above the average analyst 12-month target price of $74.44, changing hands for $75.84/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Esperion Therapeutics Inc , where a total of 3,150 contracts have traded so far, representing approximately 315,000 underlying shares. That amounts to about 56.5% of ESPR's average daily trading volume over the past month of 557,890 shares.
Jim Cramer is bullish on Delta Air Lines, BioTelemetry, TransUnion, Amgen and Littelfuse.
Jim Cramer says there's a case to be made for underpricing, even in this market.
Jim Cramer says people care about natural disasters, but the markets are moved by data points, such as Apple's iPhone news.
The most recent short interest data has been released for the 08/15/2017 settlement date, which shows a 546,557 share decrease in total short interest for Esperion Therapeutics Inc , to 4,907,536, a decrease of 10.02% since 07/31/2017. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.
Akebia Therapeutics, Sarepta Therapeutics and Esperion Therapeutics were among the biotech stock movers in premarket trading on June 29.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.